Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th:

CoreCard Corporation : This technology solutions and processing services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

CoreCard Corporation Price and Consensus

CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote

CoreCard’s shares gained 44.9% over the last three months compared with the S&P 500’s advance of 5.3%. The company possesses a Momentum Score  of A.

CoreCard Corporation Price

CoreCard Corporation price | CoreCard Corporation Quote

Entrada Therapeutics, Inc. (TRDA Quick QuoteTRDA - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.

Entrada Therapeutics, Inc. Price and Consensus

Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote

Entrada’s shares gained 8.8% over the last three months compared with the S&P 500’s advance of 5.3%. The company possesses a Momentum Score of A.

Entrada Therapeutics, Inc. Price

Entrada Therapeutics, Inc. price | Entrada Therapeutics, Inc. Quote

NRx Pharmaceuticals, Inc. (NRXP Quick QuoteNRXP - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

NRx’s shares gained 11.8% over the past month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

NRx Pharmaceuticals, Inc. Price

NRx Pharmaceuticals, Inc. price | NRx Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.